Getein Biotech, Inc 603387.SS Stock
Getein Biotech, Inc Price Chart
Getein Biotech, Inc 603387.SS Financial and Trading Overview
| Getein Biotech, Inc stock price | 8.77 CNY |
| Previous Close | 12.92 CNY |
| Open | 12.9 CNY |
| Bid | 12.94 CNY x N/A |
| Ask | 12.95 CNY x N/A |
| Day's Range | 12.9 - 13.04 CNY |
| 52 Week Range | 11.03 - 15.68 CNY |
| Volume | 2.52M CNY |
| Avg. Volume | 5.86M CNY |
| Market Cap | 6.56B CNY |
| Beta (5Y Monthly) | 0.358219 |
| PE Ratio (TTM) | 16.175 |
| EPS (TTM) | 0.5 CNY |
| Forward Dividend & Yield | 0.3 (2.36%) |
| Ex-Dividend Date | June 2, 2023 |
| 1y Target Est | N/A |
603387.SS Valuation Measures
| Enterprise Value | 6.18B CNY |
| Trailing P/E | 16.175 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.0126724 |
| Price/Book (mrq) | 2.520943 |
| Enterprise Value/Revenue | 3.778 |
| Enterprise Value/EBITDA | 14.325 |
Trading Information
Getein Biotech, Inc Stock Price History
| Beta (5Y Monthly) | 0.358219 |
| 52-Week Change | -8.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.68 CNY |
| 52 Week Low | 11.03 CNY |
| 50-Day Moving Average | 13.39 CNY |
| 200-Day Moving Average | 13.14 CNY |
603387.SS Share Statistics
| Avg. Volume (3 month) | 5.86M CNY |
| Avg. Daily Volume (10-Days) | 3.79M CNY |
| Shares Outstanding | 507.15M |
| Float | 279.33M |
| Short Ratio | N/A |
| % Held by Insiders | 49.50% |
| % Held by Institutions | 4.35% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.34 |
| Trailing Annual Dividend Yield | 2.63% |
| 5 Year Average Dividend Yield | 143.00% |
| Payout Ratio | 0.4304 |
| Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 24.56% |
| Operating Margin (ttm) | 22.21% |
| Gross Margin | 62.69% |
| EBITDA Margin | 26.37% |
Management Effectiveness
| Return on Assets (ttm) | 6.27% |
| Return on Equity (ttm) | 15.44% |
Income Statement
| Revenue (ttm) | 1.64B CNY |
| Revenue Per Share (ttm) | 3.22 CNY |
| Quarterly Revenue Growth (yoy) | -32.70% |
| Gross Profit (ttm) | 1.19B CNY |
| EBITDA | 431.35M CNY |
| Net Income Avi to Common (ttm) | 401.71M CNY |
| Diluted EPS (ttm) | 0.8 |
| Quarterly Earnings Growth (yoy) | -44.39% |
Balance Sheet
| Total Cash (mrq) | 1.1B CNY |
| Total Cash Per Share (mrq) | 2.18 CNY |
| Total Debt (mrq) | 553.3M CNY |
| Total Debt/Equity (mrq) | 19.91 CNY |
| Current Ratio (mrq) | 2.865 |
| Book Value Per Share (mrq) | 5.133 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 429.54M CNY |
| Levered Free Cash Flow (ttm) | -317498400 CNY |
Profile of Getein Biotech, Inc
| Country | China |
| State | N/A |
| City | Nanjing |
| Address | No.9 Bofu Road |
| ZIP | 211505 |
| Phone | 86 25 6856 8594 |
| Website | https://www.bio-gp.com.cn |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 2508 |
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally. The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products. It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others. The company was founded in 2002 and is headquartered in Nanjing, China.
Q&A For Getein Biotech, Inc Stock
What is a current 603387.SS stock price?
Getein Biotech, Inc 603387.SS stock price today per share is 8.77 CNY.
How to purchase Getein Biotech, Inc stock?
You can buy 603387.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Getein Biotech, Inc?
The stock symbol or ticker of Getein Biotech, Inc is 603387.SS.
Which industry does the Getein Biotech, Inc company belong to?
The Getein Biotech, Inc industry is Medical Devices.
How many shares does Getein Biotech, Inc have in circulation?
The max supply of Getein Biotech, Inc shares is 507.15M.
What is Getein Biotech, Inc Price to Earnings Ratio (PE Ratio)?
Getein Biotech, Inc PE Ratio is 17.54000000 now.
What was Getein Biotech, Inc earnings per share over the trailing 12 months (TTM)?
Getein Biotech, Inc EPS is 0.5 CNY over the trailing 12 months.
Which sector does the Getein Biotech, Inc company belong to?
The Getein Biotech, Inc sector is Healthcare.